We are delighted to welcome Immunodiagnostic Systems Holding (IDS) as the newest member of the PerkinElmer family. The acquisition of the British diagnostics company was officially closed in July 2021. In future, IDS and EUROIMMUN will closely cooperate in the fields of research and development, production as well as distribution. IDS is a leading company […]
Since end of 2020, different SARS-CoV-2 variants have appeared worldwide − alpha (B.1.1.7), beta (B.1.351), gamma (P.1/B.1.1.128) and delta (B1.617.2) − which are in part more contagious than the original virus type and are therefore spreading more quickly within populations. These variants reveal genetic changes (mutations) in the so-called receptor binding domain (RBD), which is
Six months after the start of the COVID-19 vaccination campaign in Germany, half of the population has received at least one vaccination dose. According to the Federal Ministry of Health, 37.9% of them have already been fully vaccinated (as of 02.07.2021). Currently there are four different COVID-19 vaccines available in Germany, which differ slightly in
Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 6th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany One hot-button word is still going round: Mutations. However, we are not talking of viruses. Also fungi develop in an evolutionary process. These may not be as
Britta Brix has been working for EUROIMMUN since 2012 and has been head of the department of Neurodegenerative Diseases Diagnostics since 2013, focussing on Alzheimer’s. In our interview she tells why she is interested in this subject and how she, as employee of EUROIMMUN, contributes to improved diagnostics of this severe disease. How did you
